IBDEI1OA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27986,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Chronic
 ;;^UTILITY(U,$J,358.3,27986,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,27986,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,27987,0)
 ;;=N13.6^^132^1322^73
 ;;^UTILITY(U,$J,358.3,27987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27987,1,3,0)
 ;;=3^Pyonephrosis
 ;;^UTILITY(U,$J,358.3,27987,1,4,0)
 ;;=4^N13.6
 ;;^UTILITY(U,$J,358.3,27987,2)
 ;;=^101552
 ;;^UTILITY(U,$J,358.3,27988,0)
 ;;=N30.91^^132^1322^19
 ;;^UTILITY(U,$J,358.3,27988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27988,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,27988,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,27988,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,27989,0)
 ;;=N30.90^^132^1322^20
 ;;^UTILITY(U,$J,358.3,27989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27989,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,27989,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,27989,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,27990,0)
 ;;=N41.9^^132^1322^38
 ;;^UTILITY(U,$J,358.3,27990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27990,1,3,0)
 ;;=3^Inflammatory Disease of Prostate,Unspec
 ;;^UTILITY(U,$J,358.3,27990,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,27990,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,27991,0)
 ;;=N70.91^^132^1322^75
 ;;^UTILITY(U,$J,358.3,27991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27991,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,27991,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,27991,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,27992,0)
 ;;=N70.93^^132^1322^74
 ;;^UTILITY(U,$J,358.3,27992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27992,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,27992,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,27992,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,27993,0)
 ;;=N70.92^^132^1322^55
 ;;^UTILITY(U,$J,358.3,27993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27993,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,27993,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,27993,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,27994,0)
 ;;=N73.9^^132^1322^37
 ;;^UTILITY(U,$J,358.3,27994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27994,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,27994,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,27994,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,27995,0)
 ;;=A56.11^^132^1322^36
 ;;^UTILITY(U,$J,358.3,27995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27995,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,27995,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,27995,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,27996,0)
 ;;=N73.5^^132^1322^64
 ;;^UTILITY(U,$J,358.3,27996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27996,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,27996,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,27996,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,27997,0)
 ;;=N72.^^132^1322^35
 ;;^UTILITY(U,$J,358.3,27997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27997,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,27997,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,27997,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,27998,0)
 ;;=N76.3^^132^1322^92
 ;;^UTILITY(U,$J,358.3,27998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27998,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,27998,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,27998,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,27999,0)
 ;;=N76.1^^132^1322^88
 ;;^UTILITY(U,$J,358.3,27999,1,0)
 ;;=^358.31IA^4^2
